Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 1
1967 3
1968 2
1970 3
1971 1
1972 3
1974 2
1975 7
1976 1
1977 2
1978 2
1979 6
1980 5
1982 2
1983 4
1985 4
1986 2
1987 5
1988 7
1989 6
1990 6
1991 6
1992 11
1993 12
1994 12
1995 15
1996 9
1997 15
1998 6
1999 15
2000 15
2001 14
2002 11
2003 18
2004 6
2005 12
2006 10
2007 9
2008 24
2009 16
2010 22
2011 31
2012 30
2013 30
2014 25
2015 16
2016 19
2017 24
2018 24
2019 25
2020 23
2021 26
2022 28
2023 26
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

610 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial carcinosarcoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R, Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I, Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata S, Scambia G, Monk BJ. Bogani G, et al. Int J Gynecol Cancer. 2023 Feb 6;33(2):147-174. doi: 10.1136/ijgc-2022-004073. Int J Gynecol Cancer. 2023. PMID: 36585027 Review.
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma with secondary sarcomatous trans-differentiation (conversion theory). ...The present review outlines state-of-the-art knowledge and future directions for patients with endometrial carci
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma with secondary sarcomatous trans-differentiation …
Molecular Genetics of Endometrial Carcinoma.
Bell DW, Ellenson LH. Bell DW, et al. Annu Rev Pathol. 2019 Jan 24;14:339-367. doi: 10.1146/annurev-pathol-020117-043609. Epub 2018 Oct 17. Annu Rev Pathol. 2019. PMID: 30332563 Review.
Endometrioid endometrial carcinomas constitute approximately 85% of newly diagnosed cases; serous carcinomas represent approximately 3-10% of diagnoses; clear cell carcinoma accounts for <5% of diagnoses; and uterine carcinosarcomas are rare, biphasic tumors. Longstandi …
Endometrioid endometrial carcinomas constitute approximately 85% of newly diagnosed cases; serous carcinomas represent approximately 3-10% o …
Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
Matsuzaki S, Klar M, Matsuzaki S, Roman LD, Sood AK, Matsuo K. Matsuzaki S, et al. Gynecol Oncol. 2021 Feb;160(2):586-601. doi: 10.1016/j.ygyno.2020.10.043. Epub 2020 Nov 9. Gynecol Oncol. 2021. PMID: 33183764 Review.
Uterine carcinosarcoma (UCS) is a biphasic aggressive high-grade endometrial cancer in which the sarcoma element has de-differentiated from the carcinoma element. ...
Uterine carcinosarcoma (UCS) is a biphasic aggressive high-grade endometrial cancer in which the sarcoma element has de-differentiate …
Uterine Carcinosarcomas.
Sagebiel TL, Bhosale PR, Patnana M, Faria SC, Devine CE. Sagebiel TL, et al. Semin Ultrasound CT MR. 2019 Aug;40(4):295-301. doi: 10.1053/j.sult.2019.03.004. Epub 2019 Mar 9. Semin Ultrasound CT MR. 2019. PMID: 31375170 Review.
Uterine carcinosarcoma (UCS) is a rare and aggressive variant of endometrial cancer, distinguished by its containment of both epithelial and sarcomatous elements. ...
Uterine carcinosarcoma (UCS) is a rare and aggressive variant of endometrial cancer, distinguished by its containment of both epithel …
Cutaneous carcinosarcoma: a series of six cases and a review of the literature.
Clark JJ, Bowen AR, Bowen GM, Hyngstrom JR, Hadley ML, Duffy K, Florell SR, Wada DA. Clark JJ, et al. J Cutan Pathol. 2017 Jan;44(1):34-44. doi: 10.1111/cup.12843. Epub 2016 Nov 18. J Cutan Pathol. 2017. PMID: 27730657 Review.
BACKGROUND: Cutaneous carcinosarcoma is a rare tumor with distinct malignant epithelial and mesenchymal cell populations. The histologic subtypes of epithelial and mesenchymal components in cutaneous carcinosarcoma are variable, as an assortment of carcinomatous and …
BACKGROUND: Cutaneous carcinosarcoma is a rare tumor with distinct malignant epithelial and mesenchymal cell populations. The histolo …
Frontiers of Ovarian Carcinosarcoma.
Ismail A, Choi S, Boussios S. Ismail A, et al. Curr Treat Options Oncol. 2023 Dec;24(12):1667-1682. doi: 10.1007/s11864-023-01138-4. Epub 2023 Nov 8. Curr Treat Options Oncol. 2023. PMID: 37938504 Free PMC article. Review.
Ovarian carcinosarcoma (OCS), also known as a malignant mixed Mullerian tumour (MMMT), is a rare and aggressive form of cancer that accounts for less than 5% of ovarian cancers. ...
Ovarian carcinosarcoma (OCS), also known as a malignant mixed Mullerian tumour (MMMT), is a rare and aggressive form of cancer that a …
Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.
Raffone A, Travaglino A, Raimondo D, Maletta M, De Vivo V, Visiello U, Casadio P, Seracchioli R, Zullo F, Insabato L, Mollo A. Raffone A, et al. Int J Gynaecol Obstet. 2022 Sep;158(3):520-527. doi: 10.1002/ijgo.14033. Epub 2021 Dec 11. Int J Gynaecol Obstet. 2022. PMID: 34797919 Free PMC article. Review.
BACKGROUND: It is unclear whether uterine carcinosarcoma (UCS) is more aggressive than endometrial serous carcinoma (SC) and clear cell carcinoma (CCC). ...
BACKGROUND: It is unclear whether uterine carcinosarcoma (UCS) is more aggressive than endometrial serous carcinoma (SC) and clear ce …
Uterine sarcomas.
Ganjoo KN. Ganjoo KN. Curr Probl Cancer. 2019 Aug;43(4):283-288. doi: 10.1016/j.currproblcancer.2019.06.001. Epub 2019 Jun 14. Curr Probl Cancer. 2019. PMID: 31235185 Review.
Uterine carcinosarcoma: An overview.
Pezzicoli G, Moscaritolo F, Silvestris E, Silvestris F, Cormio G, Porta C, D'Oronzo S. Pezzicoli G, et al. Crit Rev Oncol Hematol. 2021 Jul;163:103369. doi: 10.1016/j.critrevonc.2021.103369. Epub 2021 May 27. Crit Rev Oncol Hematol. 2021. PMID: 34051304 Review.
Uterine carcinosarcoma (UCS), also known as malignant mixed Mullerian tumor, is a rare gynecological malignancy characterized by poor prognosis. ...
Uterine carcinosarcoma (UCS), also known as malignant mixed Mullerian tumor, is a rare gynecological malignancy characterized by poor …
610 results